北京协和药厂有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
65
NMPA:65
Drug Approvals
Epirubicin Hydrochloride for Injection
- Product Name
- 注射用盐酸表柔比星
- Approval Number
- 国药准字H20143165
- Approval Date
- May 28, 2024
NMPA
Metformin Hydrochloride Enteric Capsules
- Product Name
- 盐酸二甲双胍肠溶胶囊
- Approval Number
- 国药准字H20103017
- Approval Date
- May 23, 2024
NMPA
Fermentaion Cordytceps Powder
- Product Name
- 发酵虫草菌粉
- Approval Number
- 国药准字Z10940040
- Approval Date
- Dec 5, 2022
NMPA
Homoharringtonine Injection
- Product Name
- 高三尖杉酯碱注射液
- Approval Number
- 国药准字H11020978
- Approval Date
- Jul 20, 2022
NMPA
Harringtonine Injection
- Product Name
- 三尖杉酯碱注射液
- Approval Number
- 国药准字H11022037
- Approval Date
- Jul 20, 2022
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next
Clinical Trials
No trials found
News
No news found